ALYSON MEADOWS: Open Payments
NPI 1982446514 · GRUNDY, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$643 in 42 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $55 · 2025 $643
Food & beverage: $643
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $166 |
| Gilead Sciences, Inc. | 3 | $70 |
| Indivior Inc. | 4 | $65 |
| Abbott Laboratories | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $21 |
Products named: VRAYLAR, CAPLYTA, SUBLOCADE, FREESTYLE LIBRE 3, Epclusa, Auvelity, MOUNJARO, MAVYRET.
Industry payments across VA — which companies pay providers there.
